BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9368727)

  • 1. Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Medical Research Council CHART Steering Committee.
    Coyle D; Drummond MF
    Clin Oncol (R Coll Radiol); 1997; 9(5):313-21. PubMed ID: 9368727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pilot studies in the economic evaluation of health technologies.
    Drummond M; Coyle D
    Int J Technol Assess Health Care; 1998; 14(3):405-18. PubMed ID: 9780528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.
    Dische S; Saunders M; Barrett A; Harvey A; Gibson D; Parmar M
    Radiother Oncol; 1997 Aug; 44(2):123-36. PubMed ID: 9288840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas.
    Khalil AA; Bentzen SM; Bernier J; Saunders MI; Horiot JC; Van Den Bogaert W; Cummings BJ; Dische S
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):568-75. PubMed ID: 12573743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with continuous hyperfractionated accelerated radiotherapy (CHART).
    Beck-Bornholdt HP; Dubben HH
    Int J Radiat Oncol Biol Phys; 1992; 23(3):678-9. PubMed ID: 1612974
    [No Abstract]   [Full Text] [Related]  

  • 9. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
    Bentzen SM; Saunders MI; Dische S
    Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.
    Saunders MI; Dische S; Barrett A; Parmar MK; Harvey A; Gibson D
    Br J Cancer; 1996 Jun; 73(12):1455-62. PubMed ID: 8664112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms. CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy.
    Griffiths GO; Parmar MK; Bailey AJ
    Br J Cancer; 1999 Dec; 81(7):1196-205. PubMed ID: 10584882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.
    Poulsen M; Denham J; Spry N; Lamb D; Peters L; Krawitz H; Penniment M; Williamson S; Tripcony L
    Australas Radiol; 1999 Nov; 43(4):487-94. PubMed ID: 10901965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer.
    Sheets NC; Wheeler SB; Kohler RE; Fried DV; Brown PM; Chera BS
    Am J Clin Oncol; 2014 Dec; 37(6):539-44. PubMed ID: 23466583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with CHART.
    Saunders MI; Dische S; Grosch EJ; Fermont DC; Ashford RF; Maher EJ; Makepeace AR
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):871-8. PubMed ID: 1651312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is double data entry necessary? The CHART trials. CHART Steering Committee. Continuous, Hyperfractionated, Accelerated Radiotherapy.
    Gibson D; Harvey AJ; Everett V; Parmar MK
    Control Clin Trials; 1994 Dec; 15(6):482-8. PubMed ID: 7851109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
    Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
    Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.
    Saunders M; Dische S; Barrett A; Harvey A; Gibson D; Parmar M
    Lancet; 1997 Jul; 350(9072):161-5. PubMed ID: 9250182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
    Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance in the CHART clinical trial.
    Aird EG; Williams C; Mott GT; Dische S; Saunders MI
    Radiother Oncol; 1995 Sep; 36(3):235-44. PubMed ID: 8532912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.